Opus Genetics, Inc.
IRD
$0.865
$0.00430.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.14M | -7.53M | -7.77M | -7.11M | -4.80M |
| Total Depreciation and Amortization | 10.00K | -- | -- | -- | 3.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.28M | 778.00K | 806.00K | 995.00K | 688.00K |
| Change in Net Operating Assets | 1.41M | 1.62M | -333.00K | 395.00K | 8.65M |
| Cash from Operations | -7.44M | -5.13M | -7.29M | -5.72M | 4.55M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.21M | -- | -- | -- | -- |
| Cash from Investing | 1.21M | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 456.00K | 1.56M | 2.48M | 3.78M |
| Repurchase of Common Stock | -37.00K | 0.00 | 0.00 | -42.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.00K | -103.00K | -22.00K | -61.00K | -172.00K |
| Cash from Financing | -83.00K | 353.00K | 1.54M | 2.38M | 3.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.31M | -4.78M | -5.75M | -3.34M | 8.15M |